Compare MXCT & STEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | STEM |
|---|---|---|
| Founded | 1999 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 93.0M | 78.4M |
| IPO Year | 2021 | 2020 |
| Metric | MXCT | STEM |
|---|---|---|
| Price | $1.01 | $10.41 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 3 |
| Target Price | $5.50 | ★ $13.33 |
| AVG Volume (30 Days) | ★ 1.0M | 149.0K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $33,026,000.00 | ★ $156,266,000.00 |
| Revenue This Year | N/A | $2.77 |
| Revenue Next Year | $18.50 | $14.65 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 8.08 |
| 52 Week Low | $0.64 | $0.41 |
| 52 Week High | $2.40 | $32.23 |
| Indicator | MXCT | STEM |
|---|---|---|
| Relative Strength Index (RSI) | 58.69 | 55.21 |
| Support Level | $0.77 | $9.81 |
| Resistance Level | $1.16 | $11.07 |
| Average True Range (ATR) | 0.07 | 0.67 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 60.11 | 69.32 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.